Filing Details

Accession Number:
0001209191-14-058011
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-15 21:27:52
Reporting Period:
2014-09-11
Filing Date:
2014-09-15
Accepted Time:
2014-09-15 21:27:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415336 Zeltiq Aesthetics Inc ZLTQ Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1547891 Sergio Garcia 4698 Willow Road, Suite 100
Pleasanton CA 94588
Svp, Gc & Corporate Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-11 2,250 $4.30 93,913 No 4 M Direct
Common Stock Disposition 2014-09-11 3,250 $25.00 90,663 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-09-11 2,250 $0.00 2,250 $4.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,500 2022-11-14 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 17, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.008, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. 25% of the total number of shares subject to the option vested on November 15, 2013, and the remainder vests in equal monthly installments over a 36 month period thereafter, subject to the Reporting Person's continued service to the Issuer.